Jail telemedicine study aims to keep opioid treatment on track after release
NCT ID NCT07524738
First seen Apr 24, 2026 · Last updated May 14, 2026 · Updated 2 times
Summary
This study tests whether giving a long-acting buprenorphine shot (BRIXADI) via telemedicine to 30 people in jail, just before they are released, helps them stay on treatment and avoid opioid use. Participants switch from daily sublingual buprenorphine to weekly and then monthly injections while still incarcerated, and are linked to a community provider after release. The main goal is to see how many injections they complete, with follow-ups at 1, 2, and 3 months post-release.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Allegany County Detention Center
Cumberland, Maryland, 21502, United States
Conditions
Explore the condition pages connected to this study.